Feng Y

Clinical Medicine Eight-Year Program, Xiangya School of Medicine, Central South University, Changsha, China.

8 papers

ArticlePsilocybin

Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.

He Z, Wang Y, Chen J +4

Europe PMC2026
ArticleKetamine

Esketamine Enhances the Chemosensitivity of Colorectal Adenocarcinoma Cells to 5-Fluorouracil via AMPK/mTOR/HMMR Signaling Pathway.

Feng Y, Tong P, Fu S +4

Europe PMC2026
ArticleKetamine

Effect of a Single Subanesthetic Dose of Esketamine on Gastrointestinal Recovery After Laparoscopic Colorectal Cancer Surgery: A Randomized, Outcome-Assessor-Blinded, Placebo-Controlled Trial

Zhang Z, Liu J, Xiang P +5

Europe PMC2026
ArticleKetamine

Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms.

Li M, Duan W, Hao X +19

Europe PMC2025
ArticleKetamine

Compare the Effects of 0 mg/kg, 0.1 mg/kg, 0.3 mg/kg and 0.5 mg/kg Esketamine on Emergence Agitation After Tonsillectomy and Adenoidectomy in Children: A Randomized Control Trial.

Jiang P, Liu W, Peng Q +4

Europe PMC2025
ArticleAyahuasca

Quantitative evaluation of multiple treatment regimens for treatment-resistant depression.

Feng Y, Lv Y, Yang J +6

Europe PMC2025
ArticleKetamine

The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor-CaMKII pathway.

Wang J, Feng Y, Qi Z +4

Europe PMC2024
ArticleKetamine

Predicting efficacy of sub-anesthetic ketamine/esketamine i.v. dose during course of cesarean section for PPD prevention, utilizing traditional logistic regression and machine learning models.

Li Q, Gao K, Yang S +11

Europe PMC2023